Evidence for a cytopathogenicity determinant in HIV-1 Vpr. - Wikidata - awgldk - TriplyDB

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

http://www.wikidata.org/entity/Q34035915

about

Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae Molecular mechanisms of HIV immune evasion of the innate immune response in myeloid cells Visualizing Vpr-induced G2 arrest and apoptosis Human immunodeficiency virus type 1 (HIV-1) Vpr-regulated cell death: insights into mechanism Retroviral DNA Integration HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT R77Q and Q3R HIV1-VPR mutations in an otherwise asymptomatic 5-year-old child with repeated ear infections Analysis of human immunodeficiency virus cytopathicity by using a new method for quantitating viral dynamics in cell culture.Vpr-host interactions during HIV-1 viral life cycle.Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage Cell cycle G2/M arrest through an S phase-dependent mechanism by HIV-1 viral protein R.The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains Study of PTPC composition during apoptosis for identification of viral protein target.The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.Mitochondrial apoptosis and the peripheral benzodiazepine receptor: a novel target for viral and pharmacological manipulation Construction of doxycyline-dependent mini-HIV-1 variants for the development of a virotherapy against leukemias Antagonistic interaction of HIV-1 Vpr with Hsf-mediated cellular heat shock response and Hsp16 in fission yeast (Schizosaccharomyces pombe)Anti-vpr activities of heat shock protein 27.Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25 A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: potential impact on CTL epitopes HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.Activation of the DNA Damage Response Is a Conserved Function of HIV-1 and HIV-2 Vpr That Is Independent of SLX4 Recruitment HIV-1 Vpr N-terminal tagging affects alternative splicing of the viral genome.Anti-Vpr activity of a yeast chaperone protein.Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.Human immunodeficiency virus type 1 Vpr polymorphisms associated with progressor and nonprogressor individuals alter Vpr-associated functions.Vpr and Vpu are important for efficient human immunodeficiency virus type 1 replication and CD4+ T-cell depletion in human lymphoid tissue ex vivo.Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.Defining the roles for Vpr in HIV-1-associated neuropathogenesis.The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R Mitochondrial dysfunction in lyssavirus-induced apoptosis.Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity.Identification of two unique naturally occurring Vpr sequence polymorphisms associated with clinical parameters in HIV-1 chronic infection.

P2860

Q24797248-638E4A45-7238-4E0F-AD0C-2B49DE82C1AA Q24804945-4E4097A0-AD79-4646-944F-AF3A8327C466 Q27022978-2D12ECCC-7118-4B0A-8DEA-C4A42471C33E Q27329545-13D559CC-23BB-4CC5-8D34-AE73A6BFF644 Q28245301-D133C457-6403-4367-891D-BDE20A992A28 Q28596842-43DCA194-CA52-4BA4-A253-B70C90DA9E8C Q33265220-59E54062-9846-488D-9EA0-31C12FD994BF Q33635218-62AB0964-7A61-4630-9164-6305F5BA71C2 Q33707384-B8983269-2392-4735-8A10-3733DB8688BA Q33828332-0BE10752-BD80-4B5E-92BE-546372D1749E Q33864438-8295C1B7-D04D-4284-8C6D-16F1EE8044C2 Q34016503-02D75EF4-117F-449D-AA43-6532178C3D36 Q34106660-68B008F6-EF6F-4819-AA27-98243D36279E Q34307368-3D239664-468A-4F94-A6DA-1A9C34E3A3EB Q34480135-4E90F7C3-D34A-4361-9C6C-72EE10F64ABD Q34712821-E3743B31-1A0F-4B3F-9054-F5009C0FFEBD Q34989649-78531A12-D50B-4917-9CC2-089239F05A64 Q35070255-911F47A0-2F64-40C5-8F1A-B32520476739 Q35689843-FEC79EDF-50E1-4AB8-9DAF-59CBA7E25D07 Q35868679-726BFA17-C29A-420C-A8C5-B1B29E32B094 Q36398981-15314C23-CA59-4DB2-A06E-F78B51783B8B Q36484010-A5CCA9FF-623D-4D88-97B8-E185D1E8CEC0 Q36484133-CFA848B5-04B5-4F80-9AF9-E930C5D01880 Q36908259-13EBDC34-BA7B-4203-8DAC-9572FD29C94B Q37029922-7272D06E-B213-416C-8F05-83E8096BBC73 Q37150920-BA6C31A9-6921-46C9-AE6F-2D098E1B05C0 Q37253817-0D26A0AB-A045-4BB0-8EBC-C2323E2872FA Q37323917-9FE70E03-E21F-4375-922A-39AADD043411 Q37567751-0B1C9BDF-1F47-467C-A09E-F65980244643 Q37574658-23B87D99-B215-420E-92F3-BFB5D50E758A Q37593214-F8B620C0-225C-4E05-A7A4-8CA3C624B7C6 Q37596639-ED747039-BD47-468E-8505-2D85E564D23B Q37950254-3EF47004-3F5E-45F2-9049-8A5A69C40924 Q38801550-77F85831-06E1-4867-8D14-D91381E5E89A Q39079514-E579D6FA-D89D-417E-8082-BD7207D2A9D9 Q39270892-2D5D02B7-374C-4877-96BF-622304103A7E Q39960685-25EE6045-2BFE-48EB-ADEF-A6823E52E341 Q40005595-B4D2F437-7BBF-45D2-A7D7-9842EF0F01CC Q40288825-F0FEF40A-756D-4F2F-9184-F1338206BFE3 Q40473791-79A809E4-5D36-44D7-8CB9-BBEB7106516F

P2860

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

http://www.wikidata.org/entity/Q34035915

description

2002 nî lūn-bûn

@nan

2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@ast

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@en

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@nl

type

label

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@ast

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@en

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@nl

prefLabel

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@ast

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@en

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@nl

P1433

Q34035915-4C23246D-C6EB-4D26-B49A-07A35A73A7D9

P1476

Q34035915-70A8509D-86BF-4730-AE3F-12EC1E6D7B64

P2093

Q34035915-4334B4B9-4DDC-4DC3-B820-2A2AB9B9DB2A

Q34035915-66FE70DD-5320-4311-B4BA-8983DCF1E1AA

Q34035915-7BD77CEF-4255-4B23-B740-A3CE4B3CD373

Q34035915-A016E2D2-B365-4728-9019-DCFA6D36F9F6

Q34035915-E33712E5-5E01-4FCC-8DDC-8DCF4AE73AFD

Q34035915-FAA4553E-D076-4BFC-8896-1A9070A85C0A

P2860

Q34035915-008818B8-9126-4148-888C-7789D6CB7B1E

Q34035915-0824B1E6-0EFB-470E-AB58-761274E0D808

Q34035915-100E8C94-7027-413E-93D8-D87D38335629

Q34035915-173D3AAB-E803-4AF2-9D74-0B36B9CFF88C

Q34035915-23FE170F-6059-4A1E-8F30-7011FF71027A

Q34035915-25C5A036-7CFA-4292-B06A-A525D34794D7

Q34035915-26281AC4-2E4C-4FE6-BC9C-621350257D31

Q34035915-2CE96559-29CF-4DCF-A36B-4F610A8BB23E

Q34035915-30745B8D-5C28-4AD0-9AF2-5878D5C6AD48

Q34035915-419F0BBB-42A5-4560-AC3C-1742E1BC827D

P304

Q34035915-AEB1D2F4-6DF5-45E1-AB51-D6F90760F28B

P31

Q34035915-5B49BDD3-01E4-4606-873A-CE6CC8C664D2

P356

Q34035915-0AAE7463-251C-4CC7-BD19-9D263814178D

P407

Q34035915-4E821060-3C90-49AA-9BCE-4122933ADA6B

P433

Q34035915-0E08F35D-7248-48E7-95D5-7205FB7B874F

P478

Q34035915-10ADBA91-A05C-4520-93C7-3F779692265D

P50

Q34035915-697DA273-9EC0-4849-9DFE-5CCB4546432C

P577

Q34035915-21D5773B-FFCB-41D7-8299-DDEC841B8E51

P5875

Q34035915-25857B35-8EF3-4991-A8F3-77775A4DC915

P698

Q34035915-EE9065A5-4FED-459A-9A5E-FF0E3338F73A

P932

Q34035915-1304D752-B30E-49D7-A188-AFED960D3676

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

@en

P2093

Beda Brichacek

http://www.w3.org/2001/XMLSchema#string

John L Sullivan

http://www.w3.org/2001/XMLSchema#string

Katherine Luzuriaga

http://www.w3.org/2001/XMLSchema#string

Mario Stevenson

http://www.w3.org/2001/XMLSchema#string

Mark Sharkey

http://www.w3.org/2001/XMLSchema#string

Mohan Somasundaran

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell

Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

Host genetic influences on HIV-1 pathogenesis.

Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells.

Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection.

Membrane-fusing capacity of the human immunodeficiency virus envelope proteins determines the efficiency of CD+ T-cell depletion in macaques infected by a simian-human immunodeficiency virus

P304

9503-9508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.142313699

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Michael Emerman

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11281725

http://www.w3.org/2001/XMLSchema#string

P698

12093916

http://www.w3.org/2001/XMLSchema#string

P932

123170

http://www.w3.org/2001/XMLSchema#string